Light therapy to help adults with insomnia fall asleep faster
Official title: Assessment of Light Therapy in Insomnia Disorder
Run by University Hospital, Strasbourg, France · NCT05715411 · Data updated 2026-11-12
This trial will test whether daily light delivered through special glasses helps adults aged 30–60 with insomnia fall asleep faster.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 60 Years |
| Sex | All |
| Enrollment | 66 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | November 28, 2024 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | August 20, 2026 |
| Trial ID | NCT05715411 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 30–60 with chronic insomnia (ICSD-3) who take longer than 30 minutes to fall asleep at least three times per week, can consent, and are not shift workers or recent long-distance travelers.
✕Probably not a fit
People outside the 30–60 age range, those with other untreated sleep disorders, pregnant or breastfeeding women, shift workers, recent long-haul travelers, or patients taking medications that disturb sleep or melatonin measurements are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 30 to 60 with insomnia (ICSD-3) and sleep latency over 30 minutes at least three times per week are randomized to receive either active light therapy via light-therapy glasses or a placebo version of the glasses. The intervention is delivered and monitored at Hôpitaux Universitaires de Strasbourg, with eligibility screening to exclude recent shift work, recent trans-meridian travel, pregnancy, certain medications, and other protections. Outcomes focus on sleep timing and latency and may include circadian markers such as dim light melatonin onset where measured. Participants must be able to give informed consent and comply with device use and clinic visits.
Why it matters
Potential benefit: If effective, this non-drug approach could shorten time to fall asleep and offer an alternative to hypnotic medications.
How similar studies have gone: Previous work on light therapy for circadian and sleep problems shows some positive effects, but its use specifically for insomnia is promising and less extensively tested than behavioral therapies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient aged 30 to 60 years * Insomnia disorders (ICSD-3) with sleep latency \>30min - 3 times a week * Patient able to understand the objectives and risks associated with the research and to give informed dated and signed consent * Patient affiliated to a social health insurance scheme * For women of childbearing age, effective contraceptive measure for the duration of the research (hormonal contraception, IUD). Exclusion Criteria: * \- Shift work in the year preceding inclusion * Trans meridian travel (\> 2 time zones) in the month preceding inclusion * Patient in exclusion period determined by a previous or ongoing study * Impossibility of giving the patient informed information (emergency patient, difficulty understanding the patient) * Patient under judicial protection * Patient under guardianship or curatorship * For a woman of childbearing age: ongoing pregnancy or breastfeeding * Drug treatment which can disturb sleep or the measurement of DLMO: corticosteroids by general route, beta-blockers in the evening, exogenous melatonin. * Phase delay syndrome defined according to the criteria of the international classification of ICSD-3 * Restless legs syndrome with IRLS score\> 20 * Other psychiatric disorders or addictive disorder (screening with the MINI structured interview) * Other medical conditions not stabilized (detected by clinical interview), only the diseases appearing in the following list will constitute a criterion of non-inclusion: * Chronic allergies * Neurological disorders * cardiovascular, respiratory, gastrointestinal, hematopoietic, visual diseases * diseases of the immune system * kidney and urinary tract diseases * endocrine and metabolic diseases * infectious diseases * epilepsy
Where it's running
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, France Recruiting
Study contacts
- Principal investigator: Patrice BOURGIN, MD — Hôpitaux Universitaires de Strasbourg
- Study coordinator: Patrice BOURGIN, MD
- Email: pbourgin@unistra.fr
- Phone: 03 88 11 64 30
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SleepCogni for children with chronic insomnia
A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Nurse-guided app-based brief behavioral therapy for insomnia in older adults
Aging adults with insomnia will be asked to try a nurse-supported, smartphone app therapy for four weeks to see if it helps with sleep.
-
Three rTMS approaches to lessen insomnia-related pain after exercise-induced muscle soreness
This study tests whether three different rTMS approaches can reduce pain sensitivity and improve recovery in adults with insomnia after inducing muscle soreness from exercise.
-
Insomnia and Sleep Disruption's Effect on Pain Sensitivity and Muscle Soreness After Exercise
This study tests whether poor sleep or insomnia affects how people feel pain and recover from exercise-induced muscle soreness in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.